Physician profile
Sharon Lorfing
NPI 1801049481
$670.71
in general payments reported to CMS, 2019-2025
12 companies · $23.75 in 2025
The $23.75 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $347 · 2024: $168 · 2025: $23.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $137.01 | 2022 | |
| On Target Laboratories, INC | $116.49 | 2024 | Cytalux |
| Astrazeneca Pharmaceuticals LP | $100.00 | 2021 | |
| Intuitive Surgical, INC. | $98.67 | 2022 | |
| Ethicon US, LLC | $68.76 | 2022 | |
| Stryker Corporation | $32.13 | 2021 | |
| Baudax Bio INC. | $24.02 | 2022 | |
| Pulmonx Corporation | $23.75 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Kci USA, INC. | $18.56 | 2022 | |
| Merck Sharp & Dohme LLC | $17.98 | 2024 | Welireg, Keytruda |
| Abbvie INC. | $17.00 | 2024 | |
| Atricure, INC. | $16.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Lorfing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.